Mucormycosis treated with posaconazole: review of 96 case reports

References

• Abuali MM, Posada R, Del Toro G, Roman E, Ramani R, Chaturvedi S, Chaturvedi V, LaBombardi VJ. (2009). Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia. J Clin Microbiol, 47, 4176–4179.
   PubMedGoogle Scholar
• Adalja A, Kaka AS. (2010). Necrotic arm lesions in an intravenous drug user. Intern Emerg Med, 5, 439–440.
   Google Scholar
• Adegbola SO, Banerjee A, Mulcahy MP. (2009). Rhinocerebral mucormycosis. Br J Hosp Med (Lond), 70, 298–299.
   Google Scholar
• Albrecht J, Meves A, Bigby M. (2009). A survey of case reports and case series of therapeutic interventions in the Archives of Dermatology. Int J Dermatol, 48, 592–597.
   Google Scholar
• Alexander BD, Perfect JR, Daly JS, Restrepo A, Tobón AM, Patino H, Hardalo CJ, Graybill JR. (2008). Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant. Transplantation, 86, 791–796.
   PubMed Web of Science ®Google Scholar
• Almaslamani M, Taj-Aldeen SJ, Garcia-Hermoso D, Dannaoui E, Alsoub H, Alkhal A. (2009). An increasing trend of cutaneous zygomycosis caused by Mycocladus corymbifer (formerly Absidia corymbifera): report of two cases and review of primary cutaneous Mycocladus infections. Med Mycol, 47, 532–538.
   PubMed Web of Science ®Google Scholar
• Barfield RC, Hale GA, Burnette K, Behm FG, Knapp K, Eldridge P, Handgretinger R. (2007). Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia. Pediatr Blood Cancer, 48, 349–353.
   PubMed Web of Science ®Google Scholar
• Barrett JP, Vardulaki KA, Conlon C, Cooke J, Daza-Ramirez P, Evans EG, Hawkey PM, Herbrecht R, Marks DI, Moraleda JM, Park GR, Senn SJ, Viscoli C; Amphotericin B Systematic Review Study Group. (2003). A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations. Clin Ther, 25, 1295–1320.
   PubMed Web of Science ®Google Scholar
• Bethge WA, Schmalzing M, Stuhler G, Schumacher U, Kröber SM, Horger M, Einsele H, Kanz L, Hebart H. (2005). Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica, 90 Suppl, ECR22.
   Google Scholar
• Boelaert JR, de Locht M, Van Cutsem J, Kerrels V, Cantinieaux B, Verdonck A, Van Landuyt HW, Schneider YJ. (1993). Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest, 91, 1979–1986.
   PubMed Web of Science ®Google Scholar
• Böhme A, Ruhnke M, Buchheidt D, Cornely OA, Einsele H, Enzensberger R, Hebart H, Heinz W, Junghanss C, Karthaus M, Krüger W, Krug U, Kubin T, Penack O, Reichert D, Reuter S, Silling G, Südhoff T, Ullmann AJ, Maschmeyer G; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). (2009). Treatment of invasive fungal infections in cancer patients–recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol, 88, 97–110.
   PubMed Web of Science ®Google Scholar
• Brugière O, Dauriat G, Mal H, Marrash-Chalha R, Fournier M, Groussard O, Besnard M, Lesèche G, Dupont B. (2005). Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy. Transplantation, 80, 1361–1362.
   Google Scholar
• Busca A, Limerutti G, Locatelli F, Barbui A, De Rosa FG, Falda M. (2012). The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis. Infection, 40, 77–80.
   Google Scholar
• Chaganti J, Marriott D, Steel T, Donovan J, Biggs N. (2011). Perineural trigeminal nerve abscess secondary to mucor sinusitis: serial diffusion-weighted MRI and literature review. Clin Radiol, 66, 1106–1109.
   Google Scholar
• Chakrabarti A, Chatterjee SS, Das A, Panda N, Shivaprakash MR, Kaur A, Varma SC, Singhi S, Bhansali A, Sakhuja V. (2009). Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J, 85, 573–581.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, Rao P, Panda N, Verma SC, Sakhuja V. (2006). The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol, 44, 335–342.
   PubMed Web of Science ®Google Scholar
• Chambers CJ, Reyes Merin M, Fung MA, Huntley A, Sharon VR. (2011). Primary cutaneous mucormycosis at sites of insulin injection. J Am Acad Dermatol, 64, e79–e81.
   PubMedGoogle Scholar
• Chan Y, Goldwater P, Saxon B. (2007). Successful treatment of cutaneous and subcutaneous zygomycosis in an immunosuppressed patient with aplastic anaemia. J Paediatr Child Health, 43, 87–89.
   PubMed Web of Science ®Google Scholar
• Chen L, Xiao Y, Wang X. (2005). Successful treatment of mucormycosis in the pulmonary artery after cardiac surgery. J Card Surg, 20, 186–188.
   Google Scholar
• Cooke DT, Pagani FD, Kaul DR, Cooke KR, Lau CL, Riddell J 4th. (2010). Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole. Mycoses, 53, 163–167.
   Google Scholar
• Cornely OA. (2008). Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection, 36, 296–313.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Vehreschild JJ, Rüping MJ. (2009). Current experience in treating invasive zygomycosis with posaconazole. Clin Microbiol Infect, 15 Suppl 5, 77–81.
   Google Scholar
• De Decker K, Van Poucke S, Wojciechowski M, Ieven M, Colpaert C, Vogelaers D, Jorens PG. (2006). Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis. Pediatr Crit Care Med, 7, 482–485.
   PubMed Web of Science ®Google Scholar
• De Pasqual A, Deprez M, Ghaye B, Frère P, Kaschten B, Hayette MP, Radermecker M, Martin D, Canivet JL. (2008). [Invasive pulmonary mucormycosis with invasion of the thoracic spine in a patient with myelodysplastic syndrome]. Rev Med Liege, 63, 702–706.
   Google Scholar
• Diwakar A, Dewan RK, Chowdhary A, Randhawa HS, Khanna G, Gaur SN. (2007). Zygomycosis–a case report and overview of the disease in India. Mycoses, 50, 247–254.
   PubMed Web of Science ®Google Scholar
• Eiden C, Peyrière H, Tichit R, Cociglio M, Amedro P, Blayac JP, Margueritte G, Hillaire-Buys D. (2007). Inherited long QT syndrome revealed by antifungals drug-drug interaction. J Clin Pharm Ther, 32, 321–324.
   PubMed Web of Science ®Google Scholar
• Ferguson TD, Schniederjan SD, Dionne-Odom J, Brandt ME, Rinaldi MG, Nolte FS, Langston A, Zimmer SM. (2007). Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes. J Clin Microbiol, 45, 1648–1651.
   Google Scholar
• Gallet P, Debourgogne A, Rivier A, Marcon N, Georgel T, Ladrière M, Vignaud JM, Jankowski R, Machouart M. (2011). Successful management of rhinosinusal zygomycosis in a renal transplant recipient. Mycoses, 54, e593–e598.
   Google Scholar
• Garbino J, Uçkay I, Amini K, Puppo M, Richter M, Lew D. (2005). Absidia posttraumatic infection: successful treatment with posaconazole. J Infect, 51, e135–e138.
   PubMedGoogle Scholar
• Garner D, Machin K. (2008). Investigation and management of an outbreak of mucormycosis in a paediatric oncology unit. J Hosp Infect, 70, 53–59.
   Google Scholar
• Gelston CD, Durairaj VD, Simoes EA. (2007). Rhino-orbital mucormycosis causing cavernous sinus and internal carotid thrombosis treated with posaconazole. Arch Ophthalmol, 125, 848–849.
   Google Scholar
• Gilman AL, Serrano A, Skelley J, Zwick D. (2006). Successful treatment of pulmonary zygomycosis with posaconazole in a recipient of a haploidentical donor stem cell transplant. Pediatr Blood Cancer, 47, 959–963.
   Google Scholar
• Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. (2004). Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma, 45, 1351–1360.
   PubMed Web of Science ®Google Scholar
• González-Ramos MM, Bertrán-Pasarell J, Guiot H, Soto R, Santana J, Amador R, Conde A. (2008). Clinical experience with posaconazole in patients with invasive mucormycosis: a case series. P R Health Sci J, 27, 328–332.
   Google Scholar
• Gonzalez CE, Rinaldi MG, Sugar AM. (2002). Zygomycosis. Infect Dis Clin North Am, 16, 895–914, vi.
   PubMed Web of Science ®Google Scholar
• Goswami R, Cabrera-Kapetanos Y, Gupta MP, Thakkar S, Bhanot N. (2010). Necrotic gastric ulcer in an elderly patient: a rare case of gastric zygomycosis. South Med J, 103, 387–388.
   Google Scholar
• Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, Herbrecht R, Langston A, Marr KA, Schiller G, Schuster M, Wingard JR, Gonzalez CE, Revankar SG, Corcoran G, Kryscio RJ, Hare R. (2006). Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother, 50, 126–133.
   PubMed Web of Science ®Google Scholar
• Hamadani M, Awan F, Villalona-Calero MA. (2010). Malignant thymoma with immunodeficiency (Good syndrome) associated with mucormycosis. Am J Clin Oncol, 33, 109.
   Google Scholar
• Harada AS, Lau W. (2007). Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole. Hawaii Med J, 66, 68–71.
   Google Scholar
• Holley A, Mayes D, Browning R. (2008). A 40-year-old man with neutropenic fever and lobar consolidation. Chest, 133, 816–819.
   Google Scholar
• Ibrahim AS, Avanessian V, Spellberg B, Edwards JE Jr. (2003). Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob Agents Chemother, 47, 3343–3344.
   PubMedGoogle Scholar
• Ibrahim M, Chitnis S, Fallon K, Roberts T. (2009). Rhinocerebral mucormycosis in a 12-year-old girl. Arch Neurol, 66, 272–273.
   Google Scholar
• Ide L, Buysschaert I, Demuynck H, De Man R, Verlinde A, De Laere E, Surmont I. (2004). Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole? Clin Microbiol Infect, 10, 862–863.
   PubMed Web of Science ®Google Scholar
• Jensen EM, Clemmensen S, Bjørndal K, Krogdahl A. (2011). [Zygomycosis (mucormycosis) in patients with haematologic malignancy]. Ugeskr Laeg, 173, 353–354.
   Google Scholar
• John BV, Chamilos G, Kontoyiannis DP. (2005). Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect, 11, 515–517.
   PubMed Web of Science ®Google Scholar
• Kahana A, Lucarelli MJ. (2007). Use of radiopaque intraorbital catheter in the treatment of sino-orbito-cranial mucormycosis. Arch Ophthalmol, 125, 1714–1715.
   PubMedGoogle Scholar
• Kok J, Gilroy N, Halliday C, Lee OC, Novakovic D, Kevin P, Chen S. (2007). Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae. J Infect, 55, e33–e36.
   Google Scholar
• Kompoti M, Michalia M, Kallitsi G, Giannopoulou P, Arabatzis M, Liapi G, Velegraki A, Trikka-Graphakos E, Clouva-Molyvdas PM. (2011). Fatal cutaneous Saksenaea vasiformis infection in a critically ill trauma patient. Mycoses, 54, e599–e601.
   Google Scholar
• Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG. (2010). Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis, 50, 1091–1100.
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ. (2012). Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis, 54 Suppl 1, S8–S15.
   Google Scholar
• Leather HL, Correll TA, Meyer CL, Schmalfuss IM, Wingard JR. (2005). Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia. Clin Adv Hematol Oncol, 3, 773–777.
   PubMedGoogle Scholar
• Lebeau O, Van Delden C, Garbino J, Robert J, Lamoth F, Passweg J, Chalandon Y. (2010). Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection. Transpl Infect Dis, 12, 269–272.
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T, Attarbaschi A, Duerken M, Garbino J, Gruhn B, Kontny U, Lüer S, Phillips R, Scholz J, Wagner HJ, Wiesel T, Groll AH. (2010). Posaconazole salvage treatment in paediatric patients: a multicentre survey. Eur J Clin Microbiol Infect Dis, 29, 1043–1045.
   PubMed Web of Science ®Google Scholar
• Leithauser M, Kahl C, Aepinus C, Prall F, Maruschke M, Riemer H, Wolff D, Jost K, Hilgendorf I, Freund M, Junghanss C. (2010). Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation. Transpl Infect Dis, 12, 251–257.
   Google Scholar
• Lionakis MS, Kontoyiannis DP. (2005). Sinus zygomycosis in a patient receiving voriconazole prophylaxis. Br J Haematol, 129, 2.
   PubMedGoogle Scholar
• Lüer S, Berger S, Diepold M, Duppenthaler A, von Gunten M, Mühlethaler K, Wolf R, Aebi C. (2009). Treatment of intestinal and hepatic mucormycosis in an immunocompromized child. Pediatr Blood Cancer, 52, 872–874.
   Google Scholar
• Margo CE, Linden C, Strickland-Marmol LB, Denietolis AL, McCaffrey JC, Kirk N. (2007). Rhinocerebral mucormycosis with perineural spread. Ophthal Plast Reconstr Surg, 23, 326–327.
   Google Scholar
• Marks DI, Kibbler C, Pagliuca A, Ribaud P, Solano C, Heussel CP, Cook G, Glasmacher A, Schlamm H, Kantecki M. (2009). Voriconazole vs itraconazole for primary prophylaxis of invasive fungal infection in allogeneic hematopoietic cell transplant recipients. In: ASM, ed. 49th ICAAC. San Francisco: ASM, M-1249A.
   Google Scholar
• Marom T, Watad W, Dan M, Roth Y. (2009). Posaconazole for bone-invading rhinomaxillary mucormycosis. Otolaryngol Head Neck Surg, 140, 610–611.
   Google Scholar
• Merchant S, Reichman R, Koval CE. (2007). Rhinocerebral zygomycosis in an HIV-infected man during therapy with an investigational CCR5 inhibitor. AIDS, 21, 1666–1669.
   PubMed Web of Science ®Google Scholar
• Mikesch JH, Rudat A, Zühlsdorf M, Berdel WE, Mesters R, Conrad B, Becker K, Fegeler W, Anthoni C. (2007). Subcutaneous zygomycosis in neutropenia. J Clin Oncol, 25, 4844–4845.
   Google Scholar
• Minet C, Bonadona A, Tabah A, Karkas A, Mescam L, Schwebel C, Hamidfar R, Pison C, Saint-Raymond C, Faure O, Salameire D, Timsit JF. (2009). [Non-fatal disseminated mucormycosis in a solid organ transplant]. Rev Mal Respir, 26, 998–1002.
   Google Scholar
• Mitchell ME, McManus M, Dietz J, Camitta BM, Szabo S, Havens P. (2010). Absidia corymbifera endocarditis: survival after treatment of disseminated mucormycosis with radical resection of tricuspid valve and right ventricular free wall. J Thorac Cardiovasc Surg, 139, e71–e72.
   Google Scholar
• NCT00634049. (2008). Open label study of isavuconazole in the treatment of patients with aspergillosis and renal impairment or of patients with invasive fungal disease caused by rare moulds, yeasts or dimorphic fungi. NCT00634049.
   Google Scholar
• Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K. (2009). Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis, 48, 265–273.
   PubMed Web of Science ®Google Scholar
• Nogueira EL, Ind PW, Friedland JS, Salama AD. (2010). Mucormycosis may mimic disease relapse in Wegener’s granulomatosis. J Rheumatol, 37, 1364–1365.
   PubMed Web of Science ®Google Scholar
• Notheis G, Tarani L, Costantino F, Jansson A, Rosenecker J, Friederici D, Belohradsky BH, Reinhardt D, Seger R, Schweinitz DV, Wintergerst U. (2006). Posaconazole for treatment of refractory invasive fungal disease. Mycoses, 49 Suppl 1, 37–41.
   Google Scholar
• Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Piccardi M, Corvatta L, D’Antonio D, Girmenia C, Martino P, Del Favero A; GIMEMA (Gruppo Italiano Malattie EMatologiche dell’Adulto) Infection Program. (2004). Mucormycosis in hematologic patients. Haematologica, 89, 207–214.
   PubMed Web of Science ®Google Scholar
• Pagano L, Valentini CG, Caira M, Fianchi L. (2009a). ZYGOMYCOSIS: current approaches to management of patients with haematological malignancies. Br J Haematol, 146, 597–606.
   Google Scholar
• Pagano L, Valentini CG, Posteraro B, Girmenia C, Ossi C, Pan A, Candoni A, Nosari A, Riva M, Cattaneo C, Rossini F, Fianchi L, Caira M, Sanguinetti M, Gesu GP, Lombardi G, Vianelli N, Stanzani M, Mirone E, Pinsi G, Facchetti F, Manca N, Savi L, Mettimano M, Selva V, Caserta I, Scarpellini P, Morace G, D’Arminio Monforte A, Grossi P, Giudici D, Tortorano AM, Bonini A, Ricci L, Picardi M, Rossano F, Fanci R, Pecile P, Fumagalli L, Ferrari L, Capecchi PL, Romano C, Busca A, Barbui A, Garzia M, Minniti RR, Farina G, Montagna MT, Bruno F, Morelli O, Chierichini A, Placanica PM, Castagnola E, Bandettini R, Giordano S, Monastero R, Tosti ME, Rossi MR, Spedini P, Piane R, Nucci M, Pallavicini F, Bassetti M, Cristini F, LA Sorda M, Viviani M. (2009b). Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother, 21, 322–329.
   PubMed Web of Science ®Google Scholar
• Page RL 2nd, Schwiesow J, Hilts A. (2007). Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. Pharmacotherapy, 27, 290–298.
   PubMed Web of Science ®Google Scholar
• Palacio-Bedoya F, Cadena JA, Thompson GR, Sutton DA, Owens AD, Patterson TF. (2010). A noninvasive renal fungus ball caused by Rhizopus–a previously unreported manifestation of zygomycosis. Med Mycol, 48, 866–869.
   Web of Science ®Google Scholar
• Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Perl TM, Oster RA, Schuster MG, Walker R, Walsh TJ, Wannemuehler KA, Chiller TM. (2010). Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis, 50, 1101–1111.
   PubMed Web of Science ®Google Scholar
• Paul S, Marty FM, Colson YL. (2006). Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. Ann Thorac Surg, 82, 338–340.
   Google Scholar
• Peel T, Daffy J, Thursky K, Stanley P, Buising K. (2008). Posaconazole as first line treatment for disseminated zygomycosis. Mycoses, 51, 542–545.
   PubMed Web of Science ®Google Scholar
• Perkhofer S, Lechner V, Lass-Flörl C; European Committee on Antimicrobial Susceptibility Testing. (2009). In vitro activity of Isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother, 53, 1645–1647.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Hollis RJ, Jones RN; SENTRY Participants Group. (2002). Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother, 46, 1032–1037.
   PubMed Web of Science ®Google Scholar
• Reddy IS, Rao NR, Shankar Reddy VM, Rao R. (2008). Primary cutaneous mucormycosis (zygomycosis) caused by Apophysomyces elegans. Indian J Dermatol Venereol Leprol, 74, 367–370.
   Google Scholar
• Reed C, Bryant R, Ibrahim AS, Edwards J Jr, Filler SG, Goldberg R, Spellberg B. (2008). Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis, 47, 364–371.
   PubMed Web of Science ®Google Scholar
• Ribes JA, Vanover-Sams CL, Baker DJ. (2000). Zygomycetes in human disease. Clin Microbiol Rev, 13, 236–301.
   PubMed Web of Science ®Google Scholar
• Rickerts V, Atta J, Herrmann S, Jacobi V, Lambrecht E, Bialek R, Just-Nübling G. (2006). Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia. Mycoses, 49 Suppl 1, 27–30.
   Google Scholar
• Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. (2005). Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis, 41, 634–653.
   PubMed Web of Science ®Google Scholar
• Roux BG, Méchinaud F, Gay-Andrieu F, Lortholary O, Dannaoui E, Hoinard D, Corradini N. (2010). Successful triple combination therapy of disseminated Absidia corymbifera infection in an adolescent with osteosarcoma. J Pediatr Hematol Oncol, 32, 131–133.
   Google Scholar
• Rüping MJ, Heinz WJ, Kindo AJ, Rickerts V, Lass-Flörl C, Beisel C, Herbrecht R, Roth Y, Silling G, Ullmann AJ, Borchert K, Egerer G, Maertens J, Maschmeyer G, Simon A, Wattad M, Fischer G, Vehreschild JJ, Cornely OA. (2010). Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother, 65, 296–302.
   PubMed Web of Science ®Google Scholar
• Rutar T, Cockerham KP. (2006). Periorbital zygomycosis (mucormycosis) treated with posaconazole. Am J Ophthalmol, 142, 187–188.
   PubMed Web of Science ®Google Scholar
• Sanduende Otero Y, Moreno López E, Rodríguez Losada M, Roibal MA. (2009). [Amphotericin and posaconazole for gastrointestinal mucormycosis]. Rev Esp Anestesiol Reanim, 56, 131–132.
   Google Scholar
• Scheckenbach K, Cornely O, Hoffmann TK, Engers R, Bier H, Chaker A, Greve J, Schipper J, Wagenmann M. (2010). Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis. Auris Nasus Larynx, 37, 322–328.
   PubMed Web of Science ®Google Scholar
• Sedlacek M, Cotter JG, Suriawinata AA, Kaneko TM, Zuckerman RA, Parsonnet J, Block CA. (2008). Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B. Am J Kidney Dis, 51, 302–306.
   Google Scholar
• Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE. (2008). Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis, 47, 674–683.
   PubMed Web of Science ®Google Scholar
• Simmons JH, Zeitler PS, Fenton LZ, Abzug MJ, Fiallo-Scharer RV, Klingensmith GJ. (2005). Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature. Pediatr Diabetes, 6, 234–238.
   Google Scholar
• Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G; European Confederation of Medical Mycology Working Group on Zygomycosis. (2011). Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect, 17, 1859–1867.
   PubMed Web of Science ®Google Scholar
• Sörensen J, Becker M, Porto L, Lambrecht E, Schuster T, Beske F, Rickerts V, Klingebiel T, Lehrnbecher T. (2006). Rhinocerebral zygomycosis in a young girl undergoing allogeneic stem cell transplantation for severe aplastic anaemia. Mycoses, 49 Suppl 1, 31–36.
   Google Scholar
• Soummer A, Mathonnet A, Scatton O, Massault PP, Paugam A, Lemiale V, Mira JP, Dannaoui E, Cariou A, Lortholary O. (2008). Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis. Antimicrob Agents Chemother, 52, 1585–1586.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Andes D, Perez M, Anglim A, Bonilla H, Mathisen GE, Walsh TJ, Ibrahim AS. (2009a). Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis. Antimicrob Agents Chemother, 53, 3122–3125.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Edwards J Jr, Ibrahim A. (2005a). Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev, 18, 556–569.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Fu Y, Edwards JE Jr, Ibrahim AS. (2005b). Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrob Agents Chemother, 49, 830–832.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Ibrahim A, Roilides E, Lewis RE, Lortholary O, Petrikkos G, Kontoyiannis DP, Walsh TJ. (2012a). Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis, 54 Suppl 1, S73–S78.
   Google Scholar
• Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP. (2012b). The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother, 67, 715–722.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. (2009b). Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis, 48, 1743–1751.
   PubMed Web of Science ®Google Scholar
• Stark D, Milliken S, Marriott D, Harkness J. (2007). Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course. J Med Microbiol, 56, 699–701.
   Google Scholar
• Stewardson AJ, Holmes NE, Ellis DH, Howden BP. (2009). Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman. Mycoses, 52, 547–549.
   PubMed Web of Science ®Google Scholar
• Sun HY, Forrest G, Gupta KL, Aguado JM, Lortholary O, Julia MB, Safdar N, Patel R, Kusne S, Singh N. (2010). Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients. Transplantation, 90, 85–92.
   PubMed Web of Science ®Google Scholar
• Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR. (2002). In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother, 46, 2310–2312.
   PubMed Web of Science ®Google Scholar
• Tarani L, Costantino F, Notheis G, Wintergerst U, Venditti M, Di Biasi C, Friederici D, Pasquino AM. (2009). Long-term posaconazole treatment and follow-up of rhino-orbital-cerebral mucormycosis in a diabetic girl. Pediatr Diabetes, 10, 289–293.
   Google Scholar
• Ting JY, Chan SY, Lung DC, Ho AC, Chiang AK, Ha SY, Tsoi NN, Chan GC. (2010). Intra-abdominal Rhizopus microsporus infection successfully treated by combined aggressive surgical, antifungal, and iron chelating therapy. J Pediatr Hematol Oncol, 32, e238–e240.
   Google Scholar
• Tobón AM, Arango M, Fernández D, Restrepo A. (2003). Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clin Infect Dis, 36, 1488–1491.
   PubMed Web of Science ®Google Scholar
• Trotter DJ, Gonis G, Cottrill E, Coombs C. (2008). Disseminated Saksenaea vasiformis in an immunocompetent host. Med J Aust, 189, 519–520.
   PubMed Web of Science ®Google Scholar
• Valentini CG, Candoni A, Fianchi L, Posteraro B, Simeone E, Costa F, Sanguinetti M, Voso MT, Caira M, Fanin R, Pagano L. (2010). Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies. Mycoses, 53, 89–92.
   Google Scholar
• van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. (2006). Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis, 42, e61–e65.
   PubMed Web of Science ®Google Scholar
• van Well GT, van Groeningen I, Debets-Ossenkopp YJ, van Furth AM, Zwaan CM. (2005). Zygomycete infection following voriconazole prophylaxis. Lancet Infect Dis, 5, 594.
   PubMedGoogle Scholar
• Vande Broek I, Schots R. (2009). Fatal cerebral zygomycosis breakthrough in a patient with acute lymphoblastic leukemia on voriconazole prophylaxis after cord blood SCT. Bone Marrow Transplant, 44, 765–766.
   Google Scholar
• Verweij PE, van der Velden WJ, Donnelly JP, Blijlevens NM, Warris A. (2007). [Invasive zygomycosis in patients treated for haematological malignancies]. Ned Tijdschr Geneeskd, 151, 2597–2602.
   Google Scholar
• von Bonin M, Hochauf K, Monecke S, Radke J, Thiede C, Bornhäuser M, Platzbecker U, Ehninger G, Illmer T. (2009). Rhinocerebral zygomycosis and subsequent treatment decisions in a young patient with AML. Leuk Res, 33, e88–e90.
   Google Scholar
• Vyzantiadis TA, Kioumi A, Papadakis E, Braimi M, Dermitzakis E, Tsitouridis I, Antoniadis A. (2009). Rhino-cerebral zygomycosis resistant to antimycotic treatment: a case report. Mycoses, 52, 87–90.
   PubMedGoogle Scholar
• Wall GC, Leman BI. (2009). Mucormycosis in a Crohn’s disease patient treated with infliximab. Digestion, 80, 182–184.
   Google Scholar
• Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ. (1998). Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis, 26, 1383–1396.
   PubMed Web of Science ®Google Scholar
• Warner GS, Smith CA. (2008). A 48-year-old man presenting with night sweats and dyspnea. Chest, 134, 434–437.
   Google Scholar
• Wildenbeest JG, Oomen MW, Brüggemann RJ, de Boer M, Bijleveld Y, van den Berg JM, Kuijpers TW, Pajkrt D. (2010). Rhizopus oryzae skin infection treated with posaconazole in a boy with chronic granulomatous disease. Pediatr Infect Dis J, 29, 578.
   Google Scholar
• Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR, Gersten ID, Mendizabal AM, Leather HL, Confer DL, Maziarz RT, Stadtmauer EA, Bolaños-Meade J, Brown J, Dipersio JF, Boeckh M, Marr KA; Blood and Marrow Transplant Clinical Trials Network. (2010). Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood, 116, 5111–5118.
   PubMed Web of Science ®Google Scholar